Who owns Omnitrope?
Omnitrope is owned by Sandoz (Switzerland, SIX: SDZ).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Sandoz Group AG Integrated Annual Report 2025. Last checked .
Key facts
- Current owner
- Sandoz Group AG reported
- Owner HQ
- 🇨🇭 Switzerland, Basel
- Origin
- 🇨🇭 Switzerland
- Founded
- 2006
- Category
- Healthcare & pharma › Drug makers › Generics & biosimilars
- Parent ticker
- SIX: SDZ
- Last verified
- · 1 sources
About Omnitrope
Omnitrope is Sandoz's somatropin, a biosimilar recombinant human growth hormone. The European Medicines Agency approved it in 2006 as the world's first biosimilar, and the FDA soon followed. The 2025 annual report says it overtook its reference medicine in 2021 and held a 32% share of the global human growth hormone market at the end of 2025.
Ownership timeline of Omnitrope
Where Omnitrope sits in Sandoz
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Sandoz ownership tree →
See the full Sandoz brand portfolio (14) →
Other brands owned by Sandoz
Sandoz controls 14 brands on Brandtree, 14 of them in healthcare & pharma.
Also in healthcare & pharma
Other brands in generics & biosimilars, and who owns them
Sandoz has more brands in generics & biosimilars on Brandtree than any other owner: 14 of 18.
| Brand | Owner | Owner based in |
|---|---|---|
| Amneal | Amneal | 🇺🇸 United States |
| Nise | Dr. Reddy's | 🇮🇳 India |
| AvKARE | Amneal | 🇺🇸 United States |
| Omez | Dr. Reddy's | 🇮🇳 India |
About the owner: Sandoz
Sandoz is a publicly listed company headquartered in Basel, Switzerland, founded in 1886. Brandtree records 14 brands under its control, and it is listed as SIX: SDZ.
Sandoz is a Basel generics and biosimilars company that traces itself to the business Alfred Kern and Edouard Sandoz founded 140 years before 2026. Sandoz and Ciba-Geigy merged into Novartis in 1996; Sandoz was later re-established as Novartis's generics and biosimilars arm and was spun off on 4 October 2023, when its shares began trading on the SIX Swiss Exchange. Its 2025 net sales were USD 11,086 million, of which biosimilars were 30%.
🇨🇭 Omnitrope and other Swiss brands
Brandtree records a controlling owner for 128 brands that began in Switzerland. 35 of them (27%) are now controlled by a company headquartered in another country; Omnitrope is not one of them.
- Bemfola — Richter 🇭🇺
- ASTRO Gaming — Logitech 🇨🇭
- Aktifit — Emmi 🇨🇭
- Andermatt-Sedrun — Vail Resorts 🇺🇸
- Artevia — Holcim 🇨🇭
- AutoScout24 (Switzerland) — SMG Swiss Marketplace Group 🇨🇭
Frequently asked questions
Who is the parent company of Omnitrope?
The parent company of Omnitrope is Sandoz, a publicly listed company headquartered in Switzerland.
Is Omnitrope Swiss?
Yes. Omnitrope originated in Switzerland in 2006 and its owner, Sandoz, is also headquartered in Switzerland.
Is Omnitrope still owned by Sandoz?
Yes. As of 21 October 2026, Omnitrope is still owned by Sandoz. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Sandoz Group AG Integrated Annual Report 2025 — Sandoz Group AG, Annual report; retrieved 21 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.